Skip to main content


Another potential vaccine competitor from the US, Modern Inc, is expected to release its first interim data on late-stage trials of its vaccine candidate which the experts believe is likely to show effective results. Moderna's vaccine candidate uses an identical mRNA technology like Pfizer.